Sinovac begins Covid-19 vaccine candidate trials in Turkey

This article was originally published here

The phase III clinical trials will assess the efficacy and safety of the CoronaVac vaccine candidate, which is developed by Sinovac Life Sciences. Sinovac’s case-driven, randomised, double-blinded and

The post Sinovac begins Covid-19 vaccine candidate trials in Turkey appeared first on Pharmaceutical Business review.